Descrizione al grafico: Celldex ( CLDX +6.63% ▲ ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialCelldex shares are climbing as Wall Street turns more optimistic on the company’s future. Investors are reacting to a wave of analyst upgrades that highlight stronger expected catalysts in 2026 and growing enthusiasm around its late-stage drug data.

Descrizione per watch list o operatività: Wolfe Research has raised its rating on Celldex to Outperform and set a new price target of $44. Other firms are also lifting their targets, arguing that the stock still looks attractively valued despite the recent rally.